1.88

2.73% 0.05

After Hours: 1.88

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $1.88, with a volume of 287.29K. It is up +2.73% in the last 24 hours and up +29.66% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Previous Close:

$1.83

Open:

$1.83

24h Volume:

287.29K

Relative Volume:

0.35

Market Cap:

$121.79M

Revenue:

$212.69M

Net Income/Loss:

$-59.00M

P/E Ratio:

-2.0135

EPS:

-0.9337

Net Cash Flow:

$-29.49M

1W Performance:

-1.57%

1M Performance:

+29.66%

6M Performance:

-69.92%

1Y Performance:

-74.32%

1-Day Range:

$1.78

$1.89

1-Week Range:

$1.72

$1.9598

52-Week Range:

$1.17

$7.78

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1106)

Industry

Medical Devices (142)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

450

Twitter

Next Earnings Date

2026-05-08

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	1.88	118.56M	212.69M	-59.00M	-29.49M	-0.9337
ABT Abbott Laboratories	87.17	152.48B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	295.25	111.40B	25.27B	3.34B	4.57B	8.6358
MDT Medtronic Plc	77.79	100.53B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	55.98	84.50B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	82.91	48.04B	6.30B	1.07B	1.34B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

May 03, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat

May 03, 2026

May 01, 2026

TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 01, 2026

Treace Medical Concepts (TMCI) to Release Earnings on Friday - MarketBeat

May 01, 2026

Apr 28, 2026

Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN

Apr 28, 2026

Apr 27, 2026

Weber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCI - MarketBeat

Apr 27, 2026

Treace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street Zen - MarketBeat

Apr 27, 2026

Apr 26, 2026

Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN

Apr 26, 2026

Apr 24, 2026

Treace to Report First Quarter 2026 Financial Results on May 8, 2026 - The Manila Times

Apr 24, 2026

Treace Medical Concepts, Inc. to Release First Quarter 2026 Financial Results and Host Conference Call - Quiver Quantitative

Apr 24, 2026

Before markets open May 8, Treace will post results and hold an 8 a.m. ET call - Stock Titan

Apr 24, 2026

Apr 23, 2026

TMCI (Treace Medical Concepts Inc.) notches narrow Q4 2025 EPS beat, shares rise 3.74 percent on positive investor sentiment.Stock Community Signals - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 22, 2026